# Lithium Carbonate

NDC: 64980-278
Generic name: Lithium Carbonate
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20180301

FDA application: ANDA205663

## Active ingredients

- LITHIUM CARBONATE: 450 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64980-278"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64980-278
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e18d105-662d-4729-aa81-00be7472adde